JP2024123220A5 - - Google Patents

Download PDF

Info

Publication number
JP2024123220A5
JP2024123220A5 JP2024102853A JP2024102853A JP2024123220A5 JP 2024123220 A5 JP2024123220 A5 JP 2024123220A5 JP 2024102853 A JP2024102853 A JP 2024102853A JP 2024102853 A JP2024102853 A JP 2024102853A JP 2024123220 A5 JP2024123220 A5 JP 2024123220A5
Authority
JP
Japan
Prior art keywords
composition
fak inhibitor
use according
fak
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024102853A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024123220A (ja
Filing date
Publication date
Priority claimed from JP2020564323A external-priority patent/JP7585045B2/ja
Application filed filed Critical
Publication of JP2024123220A publication Critical patent/JP2024123220A/ja
Publication of JP2024123220A5 publication Critical patent/JP2024123220A5/ja
Pending legal-status Critical Current

Links

JP2024102853A 2018-05-16 2024-06-26 瘢痕形成の減少の為の接着斑キナーゼ阻害剤の制御されたヒドロゲル送達 Pending JP2024123220A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201862672513P 2018-05-16 2018-05-16
US62/672,513 2018-05-16
US201962848515P 2019-05-15 2019-05-15
US62/848,515 2019-05-15
JP2020564323A JP7585045B2 (ja) 2018-05-16 2019-05-16 瘢痕形成の減少の為の接着斑キナーゼ阻害剤の制御されたヒドロゲル送達
PCT/US2019/032697 WO2019222520A1 (en) 2018-05-16 2019-05-16 Controlled hydrogel delivery of focal adhesion kinase inhibitor for decreased scar formation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020564323A Division JP7585045B2 (ja) 2018-05-16 2019-05-16 瘢痕形成の減少の為の接着斑キナーゼ阻害剤の制御されたヒドロゲル送達

Publications (2)

Publication Number Publication Date
JP2024123220A JP2024123220A (ja) 2024-09-10
JP2024123220A5 true JP2024123220A5 (https=) 2024-12-19

Family

ID=68540759

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020564323A Active JP7585045B2 (ja) 2018-05-16 2019-05-16 瘢痕形成の減少の為の接着斑キナーゼ阻害剤の制御されたヒドロゲル送達
JP2024102853A Pending JP2024123220A (ja) 2018-05-16 2024-06-26 瘢痕形成の減少の為の接着斑キナーゼ阻害剤の制御されたヒドロゲル送達

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020564323A Active JP7585045B2 (ja) 2018-05-16 2019-05-16 瘢痕形成の減少の為の接着斑キナーゼ阻害剤の制御されたヒドロゲル送達

Country Status (8)

Country Link
US (1) US12178940B2 (https=)
EP (1) EP3793589B1 (https=)
JP (2) JP7585045B2 (https=)
CN (1) CN112384238A (https=)
AU (2) AU2019269608B2 (https=)
CA (1) CA3100352A1 (https=)
ES (1) ES2980620T3 (https=)
WO (1) WO2019222520A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019222520A1 (en) * 2018-05-16 2019-11-21 The Board Of Trustees Of The Leland Stanford Junior University Controlled hydrogel delivery of focal adhesion kinase inhibitor for decreased scar formation
CN115335121A (zh) * 2020-03-26 2022-11-11 斯坦福大学托管董事会 用于组织再生的方法及其试剂盒
WO2022191812A1 (en) * 2021-03-08 2022-09-15 National Cheng Kung University Method of facilitating wound-induced hair follicle neogenesis, tissue regeneration and reducing wound stiffness
WO2023009439A1 (en) * 2021-07-30 2023-02-02 The Board Of Trustees Of The Leland Stanford Junior University Mechanotransduction disruption mediation in skin grafting methods and compositions for use in practicing the same
CN120981256A (zh) * 2023-02-24 2025-11-18 陶特纳集团研究与发展有限责任公司 伤口敷料组件
TW202528357A (zh) * 2023-12-08 2025-07-16 美商普瑞諾生物科技公司 用於降低瘢痕形成及治療皮膚傷口之方法及組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3973420B2 (ja) * 2001-12-28 2007-09-12 ライフケア技研株式会社 創傷被覆材の製造方法
US8062661B2 (en) * 2003-12-11 2011-11-22 Teikoku Pharma Usa, Inc. Methods and compositions for treating skin wounds
EP2054089B1 (en) 2006-08-03 2018-12-26 The Board of Trustees of the Leland Stanford Junior University Devices and bandages for the treatment or prevention of scars and/or keloids and methods and kits therefor
US9636362B2 (en) * 2010-03-04 2017-05-02 The Board Of Trustees Of The Leland Stanford Junior University Pullulan regenerative matrix
CN103313732B (zh) 2010-11-12 2017-07-25 日产化学工业株式会社 含有脂质肽型胶凝剂和高分子化合物的凝胶片
US9655967B2 (en) * 2011-12-09 2017-05-23 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of focal adhesion kinase for control of scar tissue formation
US20140072613A1 (en) * 2012-09-10 2014-03-13 Cynthia Lander Compositions and Methods for Treating Cutaneous Scarring
WO2019222520A1 (en) * 2018-05-16 2019-11-21 The Board Of Trustees Of The Leland Stanford Junior University Controlled hydrogel delivery of focal adhesion kinase inhibitor for decreased scar formation

Similar Documents

Publication Publication Date Title
JP2024123220A5 (https=)
JP2021524849A5 (https=)
JP6568519B2 (ja) 医療用被覆器具
US5120544A (en) Crosslinked hydrogel and method for making same
CN1929826B (zh) 干凝胶或膜形式的局部应用的药物组合物和生产方法
JP2007217431A (ja) 相変化処方の薬剤輸送
JP2001508038A (ja) 粘膜表面および身体組織に付与可能な薬学的ゲル調製物
AU2018317188B2 (en) Topical semisolid composition containing an antimicrobial agent and pirfenidone for the treatment of chronic skin damage
JP2017515869A5 (https=)
JPS62275456A (ja) 創傷保護材
JP2017514866A5 (https=)
JP2024529315A5 (https=)
RU2019109989A (ru) Раневое покрытие с гемостатическим действием и способ его создания
JP2024529479A5 (https=)
JP2024546315A (ja) 三次元生体適合性マトリックスおよび創傷管理におけるその使用
JPH07106978B2 (ja) 複合貼付製剤
JP2025148371A (ja) 有効成分を含む創傷治療および瘢痕管理製品、その製造方法および有用な製品
CN115444812B (zh) 一种具有单面生物粘附性的黏膜粘附材料及其制备方法
CN112999199A (zh) 酮咯酸氨丁三醇凝胶贴膏的制备及应用
CN118903519A (zh) 一种促进伤口愈合的含干细胞外泌体涂层的绷带及其制备工艺
RU2005126492A (ru) Способ местного лечения заболеваний слизистой оболочки полости рта, носа и тканей пародонта при воспалении
CN101180019A (zh) 用于病毒创伤的离散片
Smith et al. A Comparison of Gold Leaf and Other Occlusive Therapy: In the Management of Skin Ulcers
RU2648869C1 (ru) Способ лечения локальных ожоговых ран II-III А степени
Pal et al. Use of collagen in extraoral wounds